Abiopharma

News list

📋 Richard Hume (Director) plans to sell 20K shares of TD SYNNEX Corporation (at $234.72 each, total $4.7M) Filed: May 05, 2026 | ID: 000259

Full text

News bot May 5, 2026, 9:59 p.m.
📋 Form 144 Filing: Richard Hume

Company: TD SYNNEX Corporation

Filing Date: 2026-05-05

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 20,000
- Price per Share: $234.72
- Total Value: $4,694,400.00
- Planned Sale Date: 2026-05-05
- Broker: Goldman Sachs & Co. LLC
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-31892
- Issuer Contact Phone: 1-510-668-3400
- Issuer Address: 44201 Nobel Drive, Fremont, CA, 94538
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 80391093.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 02/02/2026, that is intended to comply with Rule 10b5-1(c).